{"id":"67826544528-01","name":"Grünenthal GmbH","registrationDate":"2010-11-14T18:46:49.326+01:00","category":2,"subCategory":3,"legal":"Gesellschaft mit beschränkter Haftung","web":"http://www.grunenthal.com","country":"Germany","headAddress":"Zieglerstraße, 6","headCity":"Aachen","headPostCode":"D-52099","headPhone":"(49)2 41 56 90","boss":"Gabriel Baertschi","bossTitle":"Mr","bossPosition":"Chairman of the Corporate Executive Board","membersCount":1,"membersFTE":"0.5","membership":"Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu as well as of the International Federation of Pharmaceutical Manufacturers &amp; Associations (IFPMA): https://www.ifpma.org/ and has signed their respective codes.&#xd;\n&#xd;\nGrünenthal is a partner in the Societal Impact of Pain (SIP) platform. More info can be found here: https://www.sip-platform.eu","memberOrga":"","goal":"Grünenthal is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. Our ambition is to deliver four to five new products to patients in diseases with high unmet medical need by 2022 and become a € 2 bn company. We are a fully integrated research &amp; development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in our R&amp;D above the industrial average, we are strongly committed to innovation aimed at helping patients.&#xd;<br />Grünenthal is an independent, family-owned company headquartered in Aachen, Germany. We are present in 30 countries with affiliates in Europe, Latin America and the US. Our products are sold in more than 100 countries and approx. 5,200 employees are working for the Grünenthal worldwide. In 2017, Grünenthal achieved revenues of approx. € 1.3 bn.","acronym":"Grünenthal","interests":"Competition, Digital economy and society, Economy, finance and the euro, Employment and Social Affairs, Humanitarian aid and civil protection, Institutional affairs, Public Health, Regional Policy, Research and innovation, Single market","euInitiatives":"Grünenthal interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property.","lastUp":"2019-02-11T20:31:36.274+01:00","customers":"","costAbsolu":"","costRange":"300000-399999","turnoverAbsolu":0,"turnoverRange":""}